TRUMP WANTS TO END SOCIAL SECURITY and then he says he

New Post Public Reply Private Reply Replies (1) Message Board
dw
246
TRUMP WANTS TO END SOCIAL SECURITY and then he says he would NEVER touch social Security!?

“There is a lot you can do in terms of entitlements, in terms of cutting, and in terms of also the theft and the bad management of entitlements, tremendous bad management of entitlements,” said Trump, the GOP’s presumptive nominee for the White House. “There’s tremendous amounts of things and numbers of things you can do.”

Even loose talk of touching Medicare and Social Security can be politically toxic in America, especially for Republicans, who have a long record of seeking to privatize the beloved programs or reduce their benefits. Almost immediately ― and in response to attacks from President Joe Biden ― Trump’s campaign put out the word that he simply meant he’d cut down on waste and inefficiency.
A day later, Trump was on the defensive during an interview with Breitbart News. “I will never do anything that will jeopardize or hurt Social Security or Medicare,” he said.

With most politicians, you could try to parse these statements, hoping to divine some insights about their true intentions and values. But Trump is not a normal politician. He rarely talks about policy and, in instances like these when he does, his statements are so hazy and full of malapropisms that they could mean almost anything.

It’s great material for “Saturday Night Live.” But if you’re a voter trying to figure out what matters to Trump or what decisions he’d make in office, you’re basically out of luck. And although an inability to speak cogently about important issues might seem like a political liability, for Trump it may actually be an asset, because it obscures his more unpopular positions.

That’s arguably what happened in 2016. And it could happen again. But 2024 is different in one crucial way. When Trump first ran for office, he was a celebrity real estate developer with zero experience as an elected official. This time around, he’s a former president.

Instead of imagining how he might govern, you can look at what he actually did — especially on three issues that matter a lot to most Americans.

Trump’s History On Abortion And Obamacare
One of those issues is reproductive rights, which my colleague Alanna Vagianos has covered in depth.

The issue has proved politically toxic for Republicans ever since the U.S. Supreme Court ruled in Dobbs v. Jackson Women’s Health Organization, ending the federal guarantee of abortion rights. In 2022 and 2023, anger over that decision helped save the Democrats from big losses; in 2024, it could help Biden keep his job.

Trump has promised to find a position on reproductive rights that will “make people happy,” as he put it on NBC’s “Meet the Press.” But in that same interview, he also said that could mean a federal ban of “a number of weeks or months or however you want to define it.” And according to The New York Times, he has privately told advisers that he thinks a 16-week ban makes sense. Such a ban would apply even in those states that have acted through legislation or constitutional amendment to keep abortion legal.


If you are trying to figure out how Trump would actually approach reproductive rights in a second term, you can try to extrapolate from those statements. Or you could look at what he actually did the last time he was in office: He filled the executive branch and judiciary with conservatives opposed to abortion rights, including the three Supreme Court justices who made the Dobbs majority possible.

A second issue is the future of the Affordable Care Act, aka Obamacare.

Republican attempts to repeal the program in 2017 sparked a furious backlash, and were perhaps the single biggest reason that Democrats took back the House in 2018.

Since then, the program has become more entrenched, with the number of Americans signing up for coverage on its marketplaces at a record level and Medicaid expansion now operating in all but 10 states. Approval of the program has never been higher, according to polling.

Obamacare was a fixture of Trump’s 2016 campaign rhetoric, and was frequently the first thing he mentioned in speeches. He has been less vocal about it this time around, though he has also said that Republicans should “never give up” on repeal and that he’s currently “looking at alternatives” to the existing program.

Here, too, you can try to discern a position or commitment in these statements. Or you can look at what Trump actually did when he was in office, when he spent nearly his first full year trying to wipe the program off the books.

Those repeal bills that provoked all the public anger? They had his full support. And despite his promises of “great health care” with “insurance for everybody,” the actual legislation he tried desperately to push through Congress would have likely left millions more uninsured and dramatically rolled back protections for people with preexisting conditions.

Trump’s History On Prescription Drug Prices
A common element between the abortion and Obamacare issues has been Trump’s deference to Republican leaders and their allies, whether it was letting the right-wing Federalist Society hand-pick court nominees or turning the details of ACA repeal over to anti-government, pro-market crusaders like then-House Speaker Paul Ryan (R-Wis.).

That’s not quite the case for a third issue: prescription drug prices.

Trump has demonstrated a real willingness to break with conservatives — and conservative orthodoxy — by attacking the drug industry. As president, he put forward a series of executive actions that many analysts thought might reduce drug prices at the margins. (His administration rushed them through the regulatory process and courts ended up blocking several.)

But Trump had a chance to do a lot more. In 2020, Democrats used their control of the House to pass a sweeping bill that would have given the federal government far more power to set drug prices. Over in the Senate, Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.) put together bipartisan legislation that, although weaker than the House version, could have been the basis for a House-Senate compromise on lowering prices for millions.

Their bill never got to the Senate floor, because Republicans controlled the chamber and Mitch McConnell, the Republican leader from Kentucky, wouldn’t allow it. Trump could have pressured GOP leadership in the Senate to relent. He didn’t. He also backed off earlier, campaign-era promises to endorse the kinds of reforms that were in the House bill.

That wasn’t the end of the story for prescription drug reform. When Biden became president and Democrats got full control of Congress for two years, they passed a version of the 2020 House bill. And it has started to take effect. The federal government is negotiating with drug manufacturers over what Medicare will pay for 10 high-cost pharmaceuticals, while seniors for the first time have protections against catastrophic out-of-pocket costs.

Biden has proposed building on those reforms — for example, by making more drugs subject to direct price negotiations. Prominent Republicans want to go in the opposite direction and are already talking about repealing the negotiation provision. They are also talking about national abortion bans, as well as changes to Medicaid and private insurance regulation that look a lot like Obamacare repeal, even if they aren’t using that name.

Trump might have a lot to say about these issues over the next few months. Or maybe only a little. What he says might or might not make a lot of sense. But the most reliable guide to a second Trump term isn’t what he says now. It’s what he did in his first.


Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dodge Roars Back to NASCAR, Revving Up Stock Gains

Updated Category News Views 0

When Dodge decides to hit the track running, they mean it. They're cranking the engines and returning to the NASCAR Cup Series after years in the shadows. This isn't just about going fast; it's about redefining speed on the stock car circuit and maybe even the market tickers. Revving an Old Engine for a New Race Let's get this out there: Dodge pulling a U-turn back into...

Continue Reading
Ultima Genomics Drives Precision Medicine Forward in Singapore

Updated Category News Views 0

A Major Milestone for Precision Medicine Ultima Genomics just nabbed a big one, folks. They're going front and center with Singapore's National Precision Medicine (NPM) Program for Phase III, marking no small feat in the ambitious world of genomics. This is more than just another feather in their cap—it's a power move in the cutthroat race for sequencing supremacy. And...

Continue Reading
Empowering Global Health: Hainan's 2026 Women's Focus

Updated Category News Views 116

Hainan Hosts a Health Heavyweight Meet Boao, Hainan, not typically on the financial radar, just played host to a global heavyweight—the 2026 International Exchange on Women and Children's Health. While the Wall Street gang's eyes are trained on market tickers, this gathering carried significant strategic weight worth monitoring. This conference attracted over 170 key...

Continue Reading
Johns Hopkins Teams with Prospect HQ for Athlete Careers

Updated Category News Views 58

Snagging a career after college isn't quite as easy as catching a football, but the folks over at Johns Hopkins University Athletics and Prospect HQ seem to think they have a playbook for it. You might raise an eyebrow hearing this, but Prospect HQ has now roped in student-athletes from over 500 colleges and universities nationwide into its talent pool. That's a hefty...

Continue Reading
Ericsson Executes Aggressive $54M Share Buyback

Updated Category News Views 62

Digging Into Ericsson's Latest Buyback Getting straight to brass tacks, the recent maneuver by Ericsson (SE0000108656)—snapping back 500,000 shares from October 26 to October 30, 2026—raised more than a few eyebrows in the financial alleys. Shelling out SEK 54.46 million in less than a week is no small potatoes, but it’s all part of a grander financial ballet...

Continue Reading
TalentNeuron Enhances Workforce Planning with New Tools

Updated Category News Views 140

A Game Changer for Workforce Strategy You ever get the feeling businesses treat workforce planning like a jigsaw puzzle, except the pieces change shape daily? Well, TalentNeuron's out here flipping the table by introducing some fancy new capabilities that'll make those pieces fit a whole lot easier. Yeah, it's about time someone thought to merge continuous workforce...

Continue Reading
New Leadership Fuels Expansion of Black Optix Tint

Updated Category News Views 90

Shifting Gears with New Leadership Black Optix Tint isn't just revamping its car-styling game; it's refueling the entire brand with the appointment of Jeff Stark as its new brand president. This guy's entry into the picture is like putting nitro in the tank of a franchise that's already got some serious road miles behind it. With over 15 years under his belt in the...

Continue Reading
YeePay's B2B Payment Innovations Target Airlines' Pain Points

Updated Category News Views 172

A New Takeoff for Airline B2B Payments Dusting off the cobwebs of traditional payment processes, YeePay has been busy at the 2026 IATA WFS & WPS, held on the glitzy floor of the Galaxy International Convention Center in Macau from October 28 to 29. They're not just chatting about travel; they're rolling out a novel way to tackle the headaches in airline B2B order...

Continue Reading
Ceva's Wireless IP Dominance Amid AI Device Surge

Updated Category News Views 104

Keeping the Wireless IP Crown Against All Odds Look, I've seen dominance play out in the markets over the years, but Ceva’s stranglehold on the wireless interface IP market is something fierce. They've got a whopping 68% market share, and folks, that’s 12 times their closest competitor. Talk about leaving the competition eating dust! For a field growing at a solid...

Continue Reading
New Study Exposes Grim Reality for Moderate Aortic Stenosis

Updated Category News Views 41

Uncovering the Stark Truth of Moderate Aortic Stenosis When you hear about heart issues, the last thing you want to think about is moderate anything. But this study out of San Diego sure throws a wrench in how we size up moderate aortic stenosis. Turns out these patients aren't just in a holding pattern—they're facing some serious storm clouds. High Stakes for...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of a $1,000 Investment in Synopsys Stock

Updated Category News Views 159

Understanding the Long-Term Value of Synopsys Stock When it comes to investing, the history and performance of a stock can tell a compelling story. For Synopsys (NASDAQ: SNPS), the narrative over the last two decades is particularly impressive. This company has not only weathered various market conditions but has also delivered an annualized return of 16.31%, eclipsing...

Continue Reading
Patria Achieves $50 Billion in Assets Under Management

Updated Category News Views 254

Patria's Impressive Third Quarter Performance Patria (NASDAQ: PAX) has recently announced its unaudited results for the third quarter, marking a notable achievement in its financial journey. The firm has achieved a milestone, with Assets Under Management (AUM) exceeding US$50 billion, significantly more than three times the AUM at the time of its initial public offering...

Continue Reading
Tech Stocks Rally Amid Mixed Investor Sentiment and Indices

Updated Category News Views 171

Market Sentiment Shifts But Caution Lingers Tuesday’s market wrapped up with the Nasdaq making a decent little rebound, gaining roughly 1%. Ain’t that a surprise? The real kicker here is the ongoing tug-of-war between fear and greed among investors—patience is wearing thin as the CNN Money Fear and Greed Index wobbles at 42.7, still stuck in the worry zone. With...

Continue Reading
Exciting Release of Find Tamagotchi on Roblox by transcosmos

Updated Category News Views 194

New Interactive Experience: Find Tamagotchi on Roblox transcosmos is thrilled to announce the launch of Find Tamagotchi on Roblox, a beloved interactive platform embraced worldwide. This innovative title is part of a broader initiative to engage fans of the iconic Tamagotchi franchise, which has been cherished by multiple generations. The adventure to find and learn about...

Continue Reading
Sesame Workshop and NewYork-Presbyterian Team Up for Health Equity

Updated Category News Views 243

Collaboration to Enhance Children's Health The partnership of Sesame Workshop and NewYork-Presbyterian aims to instill healthy habits in young children and their families. By offering free resources and engaging content, they hope to create an environment where children can thrive. Creating Joyful Learning Experiences Through this collaboration, the organizations are set...

Continue Reading